Aethlon Medical Discloses Corporate Video Presentation

SAN DIEGO, June 2 /PRNewswire-FirstCall/ -- Aethlon Medical, Inc. (OTC Bulletin Board: AEMD), the pioneer in developing therapeutic filtration devices to address infectious disease and cancer, disclosed today that a corporate video presentation is now available to be accessed online at:

http://www.wsw.com/webcast/brileyco14/aemd.ob/. If you have not previously registered, you will be prompted to complete a brief registration form.

The corporate presentation was recorded during the B. Riley 11th Annual Investor Conference held on May 26, 2010.

About Aethlon Medical

Aethlon Medical, Inc. creates diagnostic and therapeutic device solutions for infectious disease and cancer. Our lead product, the Hemopurifier® is the first-in-class medical device to selectively capture circulating viruses and immunosuppressive proteins prior to cell and organ infection. Human studies have documented the ability of our Hemopurifier® to reduce viral load in patients infected with Hepatitis-C virus (HCV) and the Human Immunodeficiency Virus (HIV). Our primary clinical and commercialization focus is to establish the Hemopurifier® as an adjunct therapy to enhance and prolong the benefit of traditional infectious disease drug regimens.

Additional information regarding Aethlon Medical can be accessed online at www.aethlonmedical.com.


Contacts:

Jim Joyce

Chairman, CEO

858.459.7800 x301

jj@aethlonmedical.com


John P. Salvador

Director, Communications and Investor Relations

858.459.7800 x307

jps@aethlonmedical.com




(Logo: http://www.newscom.com/cgi-bin/prnh/20090325/LA88762LOGO-b)

SOURCE Aethlon Medical, Inc.

Back to news